Salix pharmaceuticals, ltd. formerly salix holdings, ltd. a development stage company, develops new pharmaceuticals primarily focussing in the area of gastrointestinal disease. the company's product balsalazide disodium is presently marketed in the united kingdom. research, development and distribution accounted for 64% of 1998 revenues and gastrointestinal products, 36%.